| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Valerio Ricci, Domenico De Berardis, Giuseppe Main. Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review. Healthcare (Basel, Switzerland). vol 12. issue 3. 2024-02-10. PMID:38338224. |
this review comprehensively investigates various substances, such as cannabinoids, cocaine, amphetamines, and lsd, which exhibit a greater propensity for inducing psychosis. |
2024-02-10 |
2024-02-12 |
Not clear |
| Miriam Cotaina, Marc Peraire, Mireia Boscá, Iván Echeverria, Ana Benito, Gonzalo Har. Substance Use in the Transgender Population: A Meta-Analysis. Brain sciences. vol 12. issue 3. 2022-03-25. PMID:35326322. |
these articles included data on current tobacco use, current tobacco use disorder, current alcohol use, current alcohol use disorder, lifetime substance (all) use, current substance use (excluding tobacco and alcohol), current use of specific substances (excluding tobacco and alcohol and including cocaine, amphetamines, methamphetamines, ecstasy, stimulants, heroin, opiates, cannabis, marijuana, lsd, hallucinogens, steroids, inhalants, sedatives, ritalin or adderall, diet pills, cold medicine, prescription medications, polysubstance, other club drugs, and other illegal drugs), and current substance use disorder (excluding tobacco and alcohol). |
2022-03-25 |
2023-08-13 |
human |
| b' Ane\\xc5\\xbeka Tom\\xc3\\xa1\\xc5\\xa1kov\\xc3\\xa1, Romana \\xc5\\xa0lamberov\\xc3\\xa1, Marie \\xc4\\x8cern\\xc3\\xa. Influence of Prenatal Methamphetamine Abuse on the Brain. Epigenomes. vol 4. issue 3. 2021-12-30. PMID:34968287.' |
in the czech republic, ecstasy is the most commonly used non-cannabis drug, followed by hallucinogenic fungi, lsd, ma, cocaine, and finally heroin. |
2021-12-30 |
2023-08-13 |
Not clear |
| Angela M Thomas, Kaley J Cargile, Jannelle A Lunn, Lisa E Bake. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats. Behavioural pharmacology. vol 32. issue 6. 2021-11-05. PMID:34397448. |
stimulus substitution was assessed with mdpv and its enantiomers, other synthetic cathinones [alpha pyrrolidinopentiophenone-hydrochloride(α-pvp), 4-methylmethcathinone (4-mmc)], other dopamine agonists (cocaine, [+)-methamphetamine] and serotonin agonists [mdma, lysergic acid diethylamide (lsd)] stimulus antagonism was assessed with the dopamine d1 receptor antagonist, sch 23390 and the d2 receptor antagonist, haloperidol. |
2021-11-05 |
2023-08-13 |
rat |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
data were included from studies that satisfied the following criteria: (i) published within the last 10 years (older studies were included based on relevance), (ii) on adolescent subjects (animal or human), (iii) published in english, (iv) journal articles, systematic reviews, meta-analyses, clinical trials, observational studies (animal or human), (v) on subjects who had unipolar depression with no comorbidities, and (vi) on subjects who used cannabis [with no confounding variables such as the use of ethanol, nicotine, cocaine, lysergic acid diethylamide (lsd), and heroin; and no medical conditions such as comorbid psychosis, mania, or autism]. |
2020-09-28 |
2023-08-13 |
human |
| Pietro Papa, Antonella Valli, Marcello Di Tuccio, Giampietro Frison, Flavio Zancanaro, Eleonora Buscaglia, Carlo Alessandro Locatell. Analytically Confirmed Intoxication by 4-Fluoromethylphenidate, an Analog of Methylphenidate. Journal of analytical toxicology. vol 43. issue 5. 2020-01-07. PMID:30843073. |
analyses for classic drugs (opiates, methadone, cocaine, cannabis metabolites, amphetamines, ecstasy and lsd), ethanol, qualitative full screen by gas chromatography-mass spectrometry and targeted analysis for 50 nps by liquid chromatography-tandem mass spectrometry tested negative; comorbidities were excluded, too. |
2020-01-07 |
2023-08-13 |
Not clear |
| J. Broadbent, J.B. Appel, E.K. Michael, J.H. Ricke. Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA). Behavioural pharmacology. vol 3. issue 5. 2019-11-20. PMID:11224147. |
lsd also substituted for (+) mda; dom, mescaline, (+) amphetamine and cocaine failed to have (+) mda-like effects. |
2019-11-20 |
2023-08-12 |
rat |
| J. Broadbent, J.B. Appel, E.K. Michael, J.H. Ricke. Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA). Behavioural pharmacology. vol 3. issue 5. 2019-11-20. PMID:11224147. |
the hallucinogens (+)-lysergic acid diethylamide (lsd) and (+/-)-2,5-dimethoxy-4-methylamphetamine (dom), substituted for (-) mda; neither mescaline nor (+) amphetamine or cocaine had (-) mda-like effects. |
2019-11-20 |
2023-08-12 |
rat |
| Joseph J Palama. Predictors of disapproval toward "hard drug" use among high school seniors in the US. Prevention science : the official journal of the Society for Prevention Research. vol 15. issue 5. 2015-10-22. PMID:24101213. |
in multivariable models, lifetime alcohol use did not affect odds of disapproval and lifetime marijuana use (without the use of any "harder" drugs) lowered odds of disapproval of lsd, amphetamine, and ecstasy, but not cocaine, crack, or heroin. |
2015-10-22 |
2023-08-12 |
Not clear |
| David Baumeister, Luis M Tojo, Derek K Trac. Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic advances in psychopharmacology. vol 5. issue 2. 2015-08-05. PMID:26240749. |
this review aims to circumscribe a quick moving and growing field, and to categorize nps into five major groups based upon their 'parent' compounds: stimulants similar to cocaine, amphetamines and ecstasy; cannabinoids; benzodiazepine based drugs; dissociatives similar to ketamine and phencyclidine (pcp); and those modelled after classic hallucinogens such as lsd and psilocybin. |
2015-08-05 |
2023-08-13 |
human |
| Patrick Dawson, James D Moffat. Cardiovascular toxicity of novel psychoactive drugs: lessons from the past. Progress in neuro-psychopharmacology & biological psychiatry. vol 39. issue 2. 2013-03-19. PMID:22580238. |
the long use of ephedrine, amphetamines, cocaine, lsd and more recently 3,4-methylenedioxy-n-methylamphetamine (mdma; "ecstasy") allows us to predict with some confidence what cardiovascular risks are likely to be associated with novel psychoactive substances (nps). |
2013-03-19 |
2023-08-12 |
Not clear |
| Michael B Gatch, Michael J Forster, Aaron Janowsky, Amy J Eshlema. Abuse liability profile of three substituted tryptamines. The Journal of pharmacology and experimental therapeutics. vol 338. issue 1. 2011-08-30. PMID:21474568. |
the abuse liability profile of three synthetic hallucinogens, n,n-diisopropyltryptamine (dipt), 5-n,n-diethyl-5-methoxytryptamine (5-meo-det), and 5-methoxy-α-methyltryptamine (5-meo-amt), was tested in rats trained to discriminate hallucinogenic and psychostimulant compounds, including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (mdma), lysergic acid diethylamide (lsd), (-)-2,5-dimethoxy-4-methylamphetamine (dom), and dimethyltryptamine (dmt). |
2011-08-30 |
2023-08-12 |
rat |
| M N Verbate. Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects. Current drug abuse reviews. vol 3. issue 3. 2011-04-11. PMID:21054259. |
both lifetime total ecstasy consumption (ltec) and the effect sizes for alcohol, nicotine, amphetamine, cocaine and lysergic acid diethylamide (lsd) were regressed on the mean effect sizes (mes) of the wm subcomponents in order to study dose-response relationships. |
2011-04-11 |
2023-08-12 |
human |
| Robert J Devlin, John A Henr. Clinical review: Major consequences of illicit drug consumption. Critical care (London, England). vol 12. issue 1. 2008-06-23. PMID:18279535. |
hallucinations may follow consumption of lsd, amphetamines, or cocaine. |
2008-06-23 |
2023-08-12 |
Not clear |
| Raimondo Maria Pavari. Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy. Annali dell'Istituto superiore di sanita. vol 42. issue 4. 2007-06-27. PMID:17361073. |
all problems were correlated to cage (cut, annoyed, guilty, eye-opener) test, drug use and mix drug use; psychological problems were higher for females: anxiety for cocaine, memory and psychosomatic for opium, sleeping disorders for crack, anxiety for popper, hallucinations for lsd and hallucinogenic mushrooms. |
2007-06-27 |
2023-08-12 |
human |
| Boonying Manaboriboon, Chulathida Chomcha. Dextromethorphan abuse in Thai adolescents: A report of two cases and review of literature. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. vol 88 Suppl 8. 2006-08-22. PMID:16856446. |
the drug is also a serotonin-reuptake inhibitor and has significant interactions with other drugs that exert their effects through the serotonin pathway such as the amphetamines, cocaine, and lysergic acid (lsd). |
2006-08-22 |
2023-08-12 |
Not clear |
| Stelios Styliano. The role of religiosity in the opposition to drug use. International journal of offender therapy and comparative criminology. vol 48. issue 4. 2004-09-10. PMID:15245655. |
using an electronic mail survey of university students, data were obtained about the participants' religious beliefs, their perceptions of drug use, and their attitudes toward the use of six common drugs (alcohol, cigarettes, cocaine, heroin, lsd, and marijuana). |
2004-09-10 |
2023-08-12 |
human |
| Nele Samyn, Gert De Boeck, Michelle Wood, Caroline T J Lamers, Dick De Waard, Karel A Brookhuis, Alain G Verstraete, Wim J Riede. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic science international. vol 128. issue 1-2. 2002-10-18. PMID:12208028. |
urine screening revealed the presence of combinations such as mdma, mdea, amph, cannabis, cocaine, lsd and psilocine in the multiple-drug condition. |
2002-10-18 |
2023-08-12 |
human |
| Manfred R Moeller, Thomas Kraeme. Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Therapeutic drug monitoring. vol 24. issue 2. 2002-06-06. PMID:11897967. |
this review describes procedures for detection of the following drugs of abuse in whole blood, plasma, and serum: amphetamine, methamphetamine, 3,4-methylenedioxy methamphetamine (mdma), n-ethyl-3, 4-methylenedioxyamphetamine (mdea), 3,4-methylenedioxyamphetamine (mda), cannabinoids (delta-9-tetrahydrocannabinol [thc], 11-hydroxy-delta-9-thc, 11-nor-9-carboxy-delta-9-thc), cocaine, benzoylecgonine, ecgonine methyl ester, cocaethylene, the opiates (heroin, 6-monoacetylmorphine, morphine, or codeine), and methadone as well as gamma-hydroxybutyric acid (ghb), lysergic acid diethylamide (lsd), phencyclidine (pcp), and psilocybin/psilocin. |
2002-06-06 |
2023-08-12 |
Not clear |
| A Ortega, A Pineau, J Boniffay, J Benois-Pineau, J P Autret, C Larouss. [Use of the CD-ROM "Tox-Didact" for teaching of toxicology and pharmacology]. Therapie. vol 55. issue 1. 2000-07-12. PMID:10860025. |
this software covers a large part of toxicology in its acute and chronic pathology using several approaches: drugs (salicylics, paracetamol, lithium ...); toxins (lead, methanol, carbon monoxide ...); drug addiction and doping (cocaine, heroin, lsd, amphetamines ...); systemic targets (kidneys, skin, liver ...). |
2000-07-12 |
2023-08-12 |
Not clear |